Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hope and prognostic disclosure.

Jennifer W Mack1, Joanne Wolfe, E Francis Cook

  • 1Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA. Jennifer_mack@dfci.harvard.edu

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|December 11, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimizing Ewing Sarcoma and Osteosarcoma Biopsy Acquisition: A Children's Oncology Group Bone Tumor Committee Consensus Statement.

Journal of the National Comprehensive Cancer Network : JNCCN·2024
Same author

Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

Analysis of Local Control Outcomes and Clinical Prognostic Factors in Localized Pelvic Ewing Sarcoma Patients Treated With Radiation Therapy: A Report From the Children's Oncology Group.

International journal of radiation oncology, biology, physics·2022
Same author

Navigating prognostic communication when children with poor-prognosis cancer experience prolonged disease stability.

Pediatric blood & cancer·2022
Same author

Postoperative mortality risk prediction that incorporates intraoperative vital signs: development and internal validation in a historical cohort.

Canadian journal of anaesthesia = Journal canadien d'anesthesie·2022
Same author

Patient, Family, and Clinician Perspectives on Location of Death for Adolescents and Young Adults With Cancer.

JCO oncology practice·2022
Same journal

Biology Over Monotherapy: Mature Results From European Organisation For Research and Treatment of Cancer 22033-26033 Reaffirm Molecular Stratification, Not Treatment Sequence, Defines Prognosis in Low-Grade Glioma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Efficacy and Tolerability of Zenocutuzumab in Advanced <i>NRG1</i> Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
See all related articles

Physicians disclosing cancer prognosis to parents do not reduce hope. Greater prognostic information sharing by doctors can increase parental hope, even with poor prognoses.

Area of Science:

  • Pediatric Oncology
  • Clinical Communication
  • Patient-Reported Outcomes

Background:

  • Physicians may withhold prognostic information to protect patient hope.
  • The impact of prognostic disclosure on parental hope in pediatric cancer is not well understood.

Purpose of the Study:

  • To investigate the relationship between physician prognostic disclosure and parental hope in children with cancer.
  • To examine if prognostic disclosure influences parental hope, trust, and emotional distress.

Main Methods:

  • Surveyed 194 parents of children with cancer and their physicians.
  • Assessed parental recall of prognostic disclosure and its impact on hope.
  • Used multivariable models to analyze associations between disclosure, communication quality, and hope.

Related Experiment Videos

Main Results:

  • Nearly half of parents reported communication always made them feel hopeful.
  • Increased prognostic disclosure elements correlated with higher parental hope (OR, 1.77).
  • Disclosure significantly increased hope even with low cure likelihood (OR, 5.98) and was linked to high-quality communication (OR, 6.58).

Conclusions:

  • Prognostic disclosure by physicians does not diminish parental hope.
  • Sharing prognostic information can enhance parental hope, irrespective of the child's prognosis.
  • Effective communication strategies are crucial for supporting hope in pediatric cancer care.